Further prospective cohort studies with bigger sample size and limited duration of HU and IM are needed to prove the role of BCR-ABL/ABL ratio, MDA, HIF-1α, and P-gp on MMR achievement in chronic phase CML patient. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.